Susan Klaeger

The paper introduces MIRA-MS, a real-time AI-guided acquisition method that improves quantification of non-canonical HLA peptides in clear cell renal cell carcinoma.

This study uses Massively Parallel Ribosome Profiling to identify thousands of viral ORFs, including non-canonical ones, and shows their impact on HLA-I peptides and protein synthesis regulation.

This study evaluates diaPASEF for high-sensitivity identification and quantification of HLA-I peptides, demonstrating improved detection of neoantigens in cancer models.